Other
Nerve Block
0
Pipeline Programs↗
13
Active Trials↗
2
Companies Involved↗
Nerve Block is an early-stage landscape with 0 programs across 2 companies. The most active players are Pacira Pharmaceuticals, Inc, Heron Therapeutics.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Competition
Competitive Landscape
Bubble size = clinical trials
Approved
Phase 3
Phase 2
Phase 1
Preclinical
Key Players
Top Companies Companies ranked by the number of pipeline programs they run for this disease.
Pipeline
Programs by Phase
No pipeline programs currently tracked for this disease.
Analysis
Trial Status
95
clinical trials
Completed50 · 53%
Unknown status17 · 18%
Terminated10 · 11%
Recruiting7 · 7%
Withdrawn5 · 5%
Not yet recruiting4 · 4%
Other2 · 2%
Clinical Trials
Trial Activity
95 trials
Analgesic Effect of Supraclavicular Block and Interscalene Analgesia Versus an Intercostobrachial Nerve Block Versus PCA in Forearm Surgery
Recruiting·—·Phase 4·NCT05602636·60 enrolled
Clinical Observation of Bupivacaine Liposome for Lower Extremity Nerve Block
Not yet recruiting·—·Phase 2·NCT07366905·60 enrolled
Dorsal Nerve Block and Caudal Block in Hypospedius Repair in Children
Not yet recruiting·—·Phase 1·NCT06500286·103 enrolled
Comparison of the Efficacy of Pericapsular Nerve Group Block Alone Versus Pericapsular Nerve Group Block Combined With Superior Cluneal and Superior Gluteal Nerve Blocks in Patients Undergoing Hip Surgery
Enrolling by invitation·—·N/A·NCT07255768·60 enrolled
Page 1 of 7
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)